Stability and changes in metabolically healthy overweight or obesity and risk of future diabetes: Niigata wellness study

Obesity

Volumn 22, Issue 11, 2014, Pages 2420-2425

  Heianza, Yoriko ^a   Kato, Kiminori ^a,b   Kodama, Satoru ^a,b   Suzuki, Akiko ^a   Tanaka, Shiro ^c   Hanyu, Osamu ^a   Sato, Koji ^b   Sone, Hirohito ^a,b  

^a NIIGATA UNIVERSITY   (Japan)

^b Niigata Association of Occupational Health Inc   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DISORDERS OF CARBOHYDRATE METABOLISM; FEMALE; FUTUROLOGY; HAZARD RATIO; HEALTH STATUS; HIGH RISK PATIENT; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; IMPAIRED FASTING GLUCOSE; JAPANESE (CITIZEN); LONGITUDINAL STUDY; MALE; METABOLIC DISORDER; METABOLICALLY HEALTHY; METABOLISM; OBESITY; PHENOTYPE; PREDICTION; RISK ASSESSMENT; AGED; BLOOD; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; EPIDEMIOLOGY; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; JAPAN; MIDDLE AGED; OVERWEIGHT; RISK FACTORS;

ADULT; AGED; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; HYPERTENSION; INCIDENCE; JAPAN; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; RISK FACTORS;

EID: 84911001884     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20855     Document Type: Article

References (35)

1. Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET. Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab 2004;89:2569-2575.
2. Pataky Z, Bobbioni-Harsch E, Golay A. Open questions about metabolically normal obesity. Int J Obes (Lond) 2010;34 (Suppl) 2:S18-S23.
3. Phillips CM. Metabolically healthy obesity: definitions, determinants and clinical implications. Rev Endocr Metab Disord 2013;14:219-227.
4. Stefan N, Häring H-U, Hu FB, Schulze MB. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol 2013;1:152-162.
5. Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, Sullivan LM, et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006;91:2906-2912.
6. Arnlov J, Sundstrom J, Ingelsson E, Lind L. Impact of BMI and the metabolic syndrome on the risk of diabetes in middle-aged men. Diabetes Care 2011;34:61-65.
7. Hadaegh F, Bozorgmanesh M, Safarkhani M, Khalili D, Azizi F. Predictability of body mass index for diabetes: affected by the presence of metabolic syndrome?. BMC Public Health 2011;11:383.
8. Bo S, Musso G, Gambino R, Villois P, Gentile L, Durazzo M, et al. Prognostic implications for insulin-sensitive and insulin-resistant normal-weight and obese individuals from a population-based cohort. Am J Clin Nutr 2012;96:962-969.
9. Hwang LC, Bai CH, Sun CA, Chen CJ. Prevalence of metabolically healthy obesity and its impacts on incidences of hypertension, diabetes and the metabolic syndrome in Taiwan. Asia Pac J Clin Nutr 2012;21:227-233.
10. Kim CH, Kim HK, Bae SJ, Kim EH, Park JY. Independent impact of body mass index and metabolic syndrome on the risk of type 2 diabetes in Koreans. Metab Syndr Relat Disord 2012;10:321-325.
11. Soriguer F, Gutierrez-Repiso C, Rubio-Martin E, Garcia-Fuentes E, Almaraz MC, Colomo N, et al. Metabolically healthy but obese, a matter of time? Findings from the prospective Pizarra study. J Clin Endocrinol Metab 2013;98:2318-2325.
12. Aung K, Lorenzo C, Hinojosa MA, Haffner SM. Risk of developing diabetes and cardiovascular disease in metabolically unhealthy normal-weight and metabolically healthy obese individuals. J Clin Endocrinol Metab 2014;99:462-468.
13. Bell JA, Kivimaki M, Hamer M. Metabolically healthy obesity and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies. Obes Rev 2014;15:504-515.
14. Hinnouho GM, Czernichow S, Dugravot A, Nabi H, Brunner EJ, Kivimaki M, et al. Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study. Eur Heart J Published online: March 26, 2014. doi:10.1093/eurheartj/ehu123.
15. Jung HS, Chang Y, Yun KE, Kim CW, Choi ES, Kwon MJ, et al. Impact of body mass index, metabolic health, and weight change on incident diabetes in a Korean population. Obesity (Silver Spring) 2014;22:1880-1887.
16. Heianza Y, Arase Y, Tsuji H, Fujihara K, Saito K, Hsieh SD, et al. Metabolically healthy obesity, presence or absence of fatty liver, and risk of type 2 diabetes in Japanese individuals: Toranomon hospital health management center study 20 (TOPICS 20). J Clin Endocrinol Metab Published online: May 13, 2014. doi:10.1210/jc.2013-4427.
17. Appleton SL, Seaborn CJ, Visvanathan R, Hill CL, Gill TK, Taylor AW, et al. Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabetes Care 2013;36:2388-2394.
18. Chang Y, Ryu S, Suh BS, Yun KE, Kim CW, Cho SI. Impact of BMI on the incidence of metabolic abnormalities in metabolically healthy men. Int J Obes (Lond) 2012;36:1187-1194.
19. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33 (Suppl 1):S62-S69.
20. World Health Organization (WHO). Report of a WHO Consultation. Obesity: Preventing and Managing the Global Epidemic. WHO Technical Report Series 894. Geneva: World Health Organization; 2000.
21. Kashiwagi A, Kasuga M, Araki E, Oka Y, Hanafusa T, Ito H, et al. Committee on the standardization of diabetes mellitus-related laboratory testing of Japan diabetes society. International clinical harmonization of glycated hemoglobin in Japan: from Japan diabetes society to national glycohemoglobin standardization program values. Diabetol Int 2012;3:8-10.
22. International Diabetes Federation. The International Diabetes Federation Consensus Worldwide Definition of the Metabolic Syndrome. 2006. Available at: http://www.idf.org/webdata/docs/IDF-Meta-def-final.pdf.
23. Phillips CM, Perry IJ. Does inflammation determine metabolic health status in obese and nonobese adults? J Clin Endocrinol Metab 2013;98:E1610-E1619.
24. Brochu M, Tchernof A, Dionne IJ, Sites CK, Eltabbakh GH, Sims EA, et al. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab 2001;86:1020-1025.
25. Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, Rittig K, et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 2008;168:1609-1616.
26. Koster A, Stenholm S, Alley DE, Kim LJ, Simonsick EM, Kanaya AM, et al. Body fat distribution and inflammation among obese older adults with and without metabolic syndrome. Obesity (Silver Spring) 2010;18:2354-2361.
27. Samaropoulos XF, Hairston KG, Anderson A, Haffner SM, Lorenzo C, Montez M, et al. A metabolically healthy obese phenotype in hispanic participants in the IRAS family study. Obesity (Silver Spring) 2013;21:2303-2309.
28. Rhee EJ, Lee MK, Kim JD, Jeon WS, Bae JC, Park SE, et al. Metabolic health is a more important determinant for diabetes development than simple obesity: a 4-year retrospective longitudinal study. PLoS One 2014;9:e98369.
29. Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, et al. Epidemic obesity and type 2 diabetes in Asia. Lancet 2006;368:1681-1688.
30. Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 2009;301:2129-2140.
31. Lee K. Metabolically obese but normal weight (MONW) and metabolically healthy but obese (MHO) phenotypes in Koreans: characteristics and health behaviors. Asia Pac J Clin Nutr 2009;18:280-284.
32. Janiszewski PM, Ross R. Effects of weight loss among metabolically healthy obese men and women. Diabetes Care 2010;33:1957-1959.
33. Kantartzis K, Machann J, Schick F, Rittig K, Machicao F, Fritsche A, et al. Effects of a lifestyle intervention in metabolically benign and malign obesity. Diabetologia 2011;54:864-868.
34. Neeland IJ, Turer AT, Ayers CR, Powell-Wiley TM, Vega GL, Farzaneh-Far R, et al. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA 2012;308:1150-1159.
35. Goto A, Goto M, Noda M, Tsugane S. Incidence of type 2 diabetes in Japan: a systematic review and meta-analysis. PLoS One 2013;8:e74699.